4th Edition

Moderate to Severe Psoriasis




ISBN 9781482215168
Published March 18, 2014 by CRC Press
417 Pages 56 B/W Illustrations

USD $170.00

Prices & shipping based on shipping country


Preview

Book Description

Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.

Table of Contents

An Overview of Psoriasis, Alan Menter and Gerald Weinstein
Evaluating Psoriasis in Patients, John Koo, Jonathan Kowalski, Mark Lebwohl, Chris Kozma, Alan Menter, and Charles Ellis
Topical Agents in the Treatment of Moderate to Severe Psoriasis, Kristina Callis Duffin, and Gerald Krueger
The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO, Monica Huynh and John Koo
Systemic and Topical PUVA Therapy, Monica Huynh andWarwick Morison
Therapy of Moderate-To-Severe PSO with MTX, Gerald Weinstein, Arisa Ortiz and Anne Marie Tremaine
Systemic Retinoids, Daniel Butler, Tina Bhutani and John Koo
Cyclosporine in the treatment of severe PSO, Charles Ellis
Combination, Rotational, and Sequential Therapies, Jason Emer and Mark Lebwohl
Pediatric Psoriasis, Maya Debbaneh, Kelly Cordoro
Psoriatic Arthritis, Dafna Gladman
Etanercept for Treatment of Psoriasis, Daniel Butler and John Koo
Adalimumab in the Treatment of Psoriasis, Maya Debbaneh and John Koo
Infliximab in the treatment of PSO, Emily Becker and John Koo
New Agents: IL-17, JAK Kinase, Ethan Levin, Argentina Leon and John Koo
Ustekinumab, Ethan Levin and Andrew Blauvelt
Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of PSO, Rishu Gupta, John Koo, Jashin Wu, and Wilson Liao
The Immunomodulatory/Immunosuppressive Classification System, John Koo, Shahrad Behnam, Shahdad Behnam, Dana Bae, Melanie Tuerk, Myriam Bernal, and Robert Dubois
Goeckerman and Ingram Day Treatment Program, Rishu Gupta and John Koo

...
View More